Not Yet RecruitingNot Applicable

Hummingbird ICE Study

1,000 participantsStarted 2026-07

Plain-language summary

The goals of this observational study are to collect data and ultrasound images using the Philips VeriSight Pro intracardiac echocardiography (ICE) catheter to assess safety and effectiveness and to support development efforts of the VeriSight Pro imaging platform.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years of age * Willing to provide written, dated and signed, informed consent * Undergoing percutaneous cardiac intervention procedures in with VeriSight Pro is used Exclusion Criteria: * Contraindicated for ICE catheter placement or considerations that make placement of VeriSight not technically feasible * Known contraindicated conditions include sepsis, major coagulation abnormalities, presence of any intracardiac thrombus, presence of class IV angina or heart failure, deep vein thrombosis, or significant peripheral vascular disease

What they're measuring

Safety Endpoint

Timeframe: During procedure

Effectiveness (Technical Success)

Timeframe: During procedure

Trial details

NCT IDNCT07552272

SponsorPhilips Clinical & Medical Affairs Global

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2031-07

Contact for this trial

Lucianno Mazzaro, MS

952-266-9969 luciano.mazzaro@philips.com

View on ClinicalTrials.gov More ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION trials